Related Experiment Video
Updated: Jan 9, 2026

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
Published on: May 11, 2015
Artificial intelligence enhanced contemporary pulmonary hypertension care
Pyi Naing1,2,3,4,5, Gregory M Scalia1,3, Dale Murdoch1,3
1The Prince Charles Hospital, Australia.
Pulmonary hypertension (PH) diagnosis is challenging. Artificial intelligence (AI) offers a personalized approach to early PH identification and management, improving patient outcomes.
Area of Science:
- Cardiology and Medical Imaging
- Artificial Intelligence in Medicine
- Pulmonary Medicine
Background:
- Pulmonary hypertension (PH) is a significant public health concern linked to increased mortality.
- Diagnostic challenges and complex etiologies often lead to delayed or missed PH diagnoses.
- Early identification of PH is crucial for timely intervention and improved patient prognosis.
Purpose of the Study:
- To review the role of Artificial Intelligence (AI) in improving the early identification and management of pulmonary hypertension (PH).
- To explore how AI-assisted tools can enhance diagnostic accuracy and patient triage for PH.
- To discuss the integration of AI with clinical and echocardiographic data for personalized PH assessment.
Main Methods:
- Review of current literature on AI applications in PH diagnosis and management.
- Discussion of AI-driven echocardiography techniques, including image guidance, auto-measurement, deep phenotyping, and smart reporting.
- Exploration of multi-level AI integration combining clinical and imaging data for risk stratification.
Main Results:
- AI demonstrates potential for a simplified, personalized approach to early PH identification.
- AI-assisted triage can effectively highlight patients needing further investigation for PH.
- AI integrated with echocardiography can improve the detection of PH, particularly PH due to left heart disease.
Conclusions:
- AI technologies offer a promising avenue for enhancing the diagnosis and management of pulmonary hypertension.
- AI can democratize access to medical care by assisting in the selection of high-risk individuals for expert evaluation.
- The integration of AI into clinical workflows has the potential to significantly improve outcomes for patients with PH.
More Related Videos
04:54Invasive Hemodynamic Assessment for the Right Ventricular System and Hypoxia-Induced Pulmonary Arterial Hypertension in Mice
Published on: October 24, 2019
07:29The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats
Published on: March 8, 2019
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Heart Failure VI: Adjunct Therapies